BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6327038)

  • 1. Phase II trial of prednimustine in glioblastoma multiforme.
    Andersen J; Christensen L; Kongsholm H
    Cancer Treat Rep; 1984 May; 68(5):795-7. PubMed ID: 6327038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednimustine in advanced breast cancer: a review.
    Mouridsen HT
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):27-31. PubMed ID: 3513318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase III trial comparing prednimustine (LEO 1031) to chlorambucil plus prednisolone in advanced breast cancer.
    Løber J; Mouridsen HT; Christiansen IE; Dombernowsky P; Mattsson W; Rørth M
    Cancer; 1983 Nov; 52(9):1570-6. PubMed ID: 6352005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
    Levin VA; Uhm JH; Jaeckle KA; Choucair A; Flynn PJ; Yung WKA ; Prados MD; Bruner JM; Chang SM; Kyritsis AP; Gleason MJ; Hess KR
    Clin Cancer Res; 2000 Oct; 6(10):3878-84. PubMed ID: 11051233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of prednimustine (NSC-134087) in the treatment of small-cell anaplastic carcinoma of the lung.
    Jensen HS; Hansen HH; Dombernowsky P
    Cancer Chemother Pharmacol; 1980; 4(4):259-61. PubMed ID: 6254684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prednimustine in advanced malignant melanoma: a phase II study.
    Pedersen L; Løber J; Dalmark M; Mouridsen HT
    Cancer Treat Rep; 1987 Dec; 71(12):1315-6. PubMed ID: 3690549
    [No Abstract]   [Full Text] [Related]  

  • 7. Prednimustine in elderly patients with multiple myeloma: a phase II study.
    Tirelli U; Sorio R; Magri MD; Zagonel V; Vaccher E; Carbone A; Trovò M; Grigoletto E
    Cancer Treat Rep; 1986 Apr; 70(4):537-8. PubMed ID: 3698051
    [No Abstract]   [Full Text] [Related]  

  • 8. Prednimustine in combination with methotrexate and 5-FU (PMF): a pilot study.
    Boesen E; Mouridsen HT
    Cancer Treat Rep; 1982 Dec; 66(12):2081-3. PubMed ID: 7139649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
    Rankin EM; Harvey C; Knight RK; Rubens RD
    Cancer Treat Rep; 1987 Nov; 71(11):1107-8. PubMed ID: 3119205
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trial of prednimustine, L-1031, (NSC-134087) in advanced breast cancer.
    Mouridsen HT; Kristensen D; Nielsen JH; Dombernowsky P
    Cancer; 1980 Jul; 46(2):253-5. PubMed ID: 7388770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednimustine in refractory non-Hodgkin's lymphoma: a phase II study of the Northern California Oncology Group.
    Gandara DR; Wold HG; Redmond J; Kohler M; Reynolds R; Wong P; Forsythe J; Fisher K; Lewis B
    Semin Oncol; 1986 Mar; 13(1 Suppl 1):14-8. PubMed ID: 3952517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
    Gross MW; Altscher R; Brandtner M; Haeusser-Mischlich H; Chiricuta IC; Siegmann AD; Engenhart-Cabillic R
    Clin Neurol Neurosurg; 2005 Apr; 107(3):207-13. PubMed ID: 15823676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III study of prednimustine (LEO 1031) in advanced breast cancer. A preliminary report.
    Rørth M; Løber J; Dombernowsky P; Krusenstjerna-Hofstrom D; Mattsson W; Mouridsen HT
    Eur J Cancer (1965); 1980; Suppl 1():137-40. PubMed ID: 7032923
    [No Abstract]   [Full Text] [Related]  

  • 14. [A phase II study of prednimustine in advanced ovarian cancer].
    Grundsell H; Johnsson JE; Tropé C
    Lakartidningen; 1980 Sep; 77(39):3394-7. PubMed ID: 6161283
    [No Abstract]   [Full Text] [Related]  

  • 15. A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: a phase II pilot study.
    Dazzi C; Cariello A; Giannini M; Del Duca M; Giovanis P; Fiorentini G; Leoni M; Rosti G; Turci D; Tienghi A; Vertogen B; Zumaglini F; De Giorgi U; Marangolo M
    Anticancer Res; 2000; 20(1B):515-8. PubMed ID: 10769716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Phase II study of prednimustine in follicular lymphoma and chronic lymphocytic leukemia].
    Ito Y; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Nakamura T; Ueno K; Imajou K; Miyaoka K; Ozeki H
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):173-8. PubMed ID: 3541792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prednimustine in adult acute myeloid leukaemia.
    Brandt L; Könyves I
    Cancer Chemother Pharmacol; 1979; 2(2):133-6. PubMed ID: 394873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of concurrent topotecan and radiation on 6-month progression-free survival in the primary treatment of glioblastoma multiforme.
    Grabenbauer GG; Gerber KD; Ganslandt O; Richter A; Klautke G; Birkmann J; Meyer M
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):164-9. PubMed ID: 19695435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of prednimustine in children with recurrent cancer: a Children's Cancer Study Group report.
    Gaynon PS; Baum ES; Krivit W; Hammond D
    Cancer Treat Rep; 1982 Jul; 66(7):1583-4. PubMed ID: 6284362
    [No Abstract]   [Full Text] [Related]  

  • 20. A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts.
    Gandara DR; Ries CA; Schiff SA; George CB; Lewis JP; Koretz MM; Carter SK
    Cancer Chemother Pharmacol; 1982; 9(1):10-2. PubMed ID: 7139848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.